Jeffrey Peters
Concepts (509)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Esophageal Neoplasms | 53 | 1993 | 37 |
Why?
| Barrett Esophagus | 52 | 1992 | 14 |
Why?
| Gastroesophageal Reflux | 69 | 1992 | 24 |
Why?
| Adenocarcinoma | 47 | 1993 | 167 |
Why?
| Esophagus | 46 | 1992 | 49 |
Why?
| Esophagectomy | 31 | 1993 | 14 |
Why?
| Fundoplication | 27 | 1995 | 11 |
Why?
| Hernia, Hiatal | 14 | 1994 | 8 |
Why?
| Laparoscopy | 22 | 1991 | 52 |
Why?
| Esophagoscopy | 27 | 1992 | 22 |
Why?
| Homeodomain Proteins | 6 | 2007 | 53 |
Why?
| Esophagogastric Junction | 22 | 1995 | 10 |
Why?
| Esophageal Diseases | 9 | 1992 | 10 |
Why?
| Bile Acids and Salts | 7 | 1997 | 18 |
Why?
| Esophageal Achalasia | 6 | 1995 | 6 |
Why?
| Middle Aged | 106 | 1991 | 1161 |
Why?
| Humans | 160 | 1991 | 1856 |
Why?
| Manometry | 23 | 1992 | 14 |
Why?
| Precancerous Conditions | 7 | 1997 | 29 |
Why?
| Male | 117 | 1991 | 1553 |
Why?
| Aged, 80 and over | 47 | 1991 | 599 |
Why?
| Stomach | 8 | 1995 | 44 |
Why?
| Aged | 79 | 1991 | 988 |
Why?
| Female | 112 | 1991 | 1643 |
Why?
| Hydrogen-Ion Concentration | 33 | 1992 | 176 |
Why?
| General Surgery | 7 | 1993 | 34 |
Why?
| RNA, Messenger | 10 | 2000 | 394 |
Why?
| Endoscopy, Digestive System | 7 | 1997 | 8 |
Why?
| Cholecystectomy, Laparoscopic | 6 | 1993 | 8 |
Why?
| Adult | 80 | 1991 | 1317 |
Why?
| Esophageal Motility Disorders | 8 | 1993 | 1 |
Why?
| Intestines | 5 | 1998 | 83 |
Why?
| Treatment Outcome | 39 | 1994 | 661 |
Why?
| Patient Selection | 5 | 1995 | 155 |
Why?
| Mucins | 2 | 2007 | 26 |
Why?
| Follow-Up Studies | 32 | 1991 | 553 |
Why?
| Esophagitis | 5 | 1998 | 11 |
Why?
| Surgical Procedures, Elective | 4 | 1993 | 31 |
Why?
| Emergencies | 3 | 1993 | 57 |
Why?
| Gastric Acid | 12 | 1992 | 12 |
Why?
| Retrospective Studies | 25 | 1993 | 653 |
Why?
| Deoxycholic Acid | 2 | 2008 | 7 |
Why?
| Postoperative Complications | 13 | 1991 | 305 |
Why?
| Prevalence | 11 | 1994 | 281 |
Why?
| Polyvinyls | 4 | 2003 | 8 |
Why?
| Neoplasm Staging | 15 | 1993 | 125 |
Why?
| Carcinoma, Squamous Cell | 5 | 1993 | 111 |
Why?
| Lymph Node Excision | 6 | 1994 | 30 |
Why?
| Preoperative Care | 6 | 1994 | 93 |
Why?
| Cancer Care Facilities | 1 | 2010 | 14 |
Why?
| Receptor, Epidermal Growth Factor | 2 | 2006 | 54 |
Why?
| Esophageal Perforation | 1 | 2010 | 10 |
Why?
| Catheter Ablation | 2 | 2008 | 38 |
Why?
| Hematoporphyrin Photoradiation | 1 | 2010 | 5 |
Why?
| Gastrectomy | 6 | 1993 | 13 |
Why?
| Thoracic Surgery | 1 | 2009 | 16 |
Why?
| Military Medicine | 1 | 2009 | 14 |
Why?
| Neoplasm Recurrence, Local | 5 | 1993 | 118 |
Why?
| Kyphosis | 1 | 2009 | 8 |
Why?
| Positron-Emission Tomography | 1 | 2009 | 32 |
Why?
| Patient Admission | 1 | 2009 | 72 |
Why?
| Clinical Competence | 4 | 2001 | 130 |
Why?
| Lymph | 1 | 2009 | 11 |
Why?
| Population Surveillance | 1 | 2009 | 70 |
Why?
| Cardia | 11 | 1993 | 3 |
Why?
| Receptors, Notch | 1 | 2009 | 30 |
Why?
| Lymph Nodes | 2 | 1999 | 106 |
Why?
| Vascular Diseases | 1 | 2009 | 60 |
Why?
| Eosinophilia | 1 | 2009 | 24 |
Why?
| Lymphatic Metastasis | 10 | 1994 | 77 |
Why?
| Colon | 4 | 1995 | 44 |
Why?
| Mucous Membrane | 8 | 1999 | 37 |
Why?
| Tomography, X-Ray Computed | 4 | 1994 | 321 |
Why?
| Wounds and Injuries | 1 | 2009 | 68 |
Why?
| Metaplasia | 14 | 1994 | 18 |
Why?
| Photochemotherapy | 1 | 2008 | 18 |
Why?
| Cholecystectomy | 4 | 1991 | 16 |
Why?
| Prosthesis Implantation | 2 | 2003 | 23 |
Why?
| Epithelial Cells | 1 | 2008 | 135 |
Why?
| Prostheses and Implants | 2 | 2003 | 47 |
Why?
| Decision Making | 1 | 2008 | 130 |
Why?
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 66 |
Why?
| Physical Examination | 1 | 2006 | 71 |
Why?
| Medical History Taking | 1 | 2006 | 53 |
Why?
| Young Adult | 4 | 2008 | 380 |
Why?
| Adolescent | 27 | 1991 | 891 |
Why?
| Polymethyl Methacrylate | 1 | 2005 | 13 |
Why?
| Digestive System Diseases | 1 | 2004 | 4 |
Why?
| Cholelithiasis | 4 | 1991 | 16 |
Why?
| Peroxidases | 1 | 2004 | 24 |
Why?
| Cyclooxygenase 2 | 5 | 2004 | 77 |
Why?
| Laparotomy | 1 | 2004 | 24 |
Why?
| Prospective Studies | 17 | 1991 | 545 |
Why?
| Barium Sulfate | 2 | 2000 | 13 |
Why?
| Anti-Ulcer Agents | 2 | 2000 | 4 |
Why?
| Sensitivity and Specificity | 8 | 1995 | 427 |
Why?
| Omeprazole | 2 | 2000 | 6 |
Why?
| Deglutition Disorders | 8 | 1994 | 19 |
Why?
| Duodenum | 5 | 1991 | 24 |
Why?
| Education, Medical, Continuing | 1 | 2004 | 54 |
Why?
| Severity of Illness Index | 8 | 1997 | 358 |
Why?
| Signal Transduction | 2 | 2009 | 313 |
Why?
| Esophageal Sphincter, Lower | 3 | 1997 | 4 |
Why?
| Survival Rate | 9 | 1994 | 250 |
Why?
| Biocompatible Materials | 1 | 2003 | 32 |
Why?
| Pneumoperitoneum, Artificial | 2 | 1996 | 5 |
Why?
| Contrast Media | 2 | 2000 | 116 |
Why?
| Gene Expression Regulation | 4 | 2007 | 277 |
Why?
| History, 20th Century | 4 | 1991 | 111 |
Why?
| Kaplan-Meier Estimate | 3 | 2010 | 89 |
Why?
| Monitoring, Physiologic | 8 | 1992 | 81 |
Why?
| Hernia, Ventral | 1 | 2001 | 8 |
Why?
| Gene Expression | 5 | 2004 | 291 |
Why?
| Surgical Instruments | 1 | 2001 | 35 |
Why?
| Logistic Models | 6 | 1992 | 251 |
Why?
| Gastric Acidity Determination | 6 | 1994 | 8 |
Why?
| Surgical Procedures, Minimally Invasive | 3 | 1998 | 23 |
Why?
| Carbon Dioxide | 3 | 1996 | 90 |
Why?
| Tumor Markers, Biological | 6 | 1995 | 112 |
Why?
| Endoscopy | 4 | 1997 | 45 |
Why?
| Gastric Mucosa | 5 | 2000 | 18 |
Why?
| Electric Impedance | 3 | 2003 | 14 |
Why?
| Odds Ratio | 3 | 1999 | 157 |
Why?
| United States | 6 | 1999 | 604 |
Why?
| Gene Expression Regulation, Neoplastic | 6 | 2000 | 126 |
Why?
| Biopsy | 12 | 1994 | 207 |
Why?
| Time Factors | 17 | 1992 | 896 |
Why?
| Risk Assessment | 6 | 2002 | 324 |
Why?
| Length of Stay | 5 | 1991 | 166 |
Why?
| Peristalsis | 4 | 1999 | 6 |
Why?
| Stomach Neoplasms | 5 | 1993 | 28 |
Why?
| Proton Pumps | 6 | 2000 | 12 |
Why?
| Statistics, Nonparametric | 9 | 1995 | 141 |
Why?
| Predictive Value of Tests | 4 | 1994 | 321 |
Why?
| Duodenogastric Reflux | 5 | 1994 | 1 |
Why?
| Cohort Studies | 5 | 2002 | 332 |
Why?
| Deglutition | 2 | 2003 | 14 |
Why?
| Mucin-2 | 2 | 2007 | 4 |
Why?
| Reoperation | 5 | 1994 | 106 |
Why?
| Neoplasm Invasiveness | 4 | 1994 | 105 |
Why?
| Chi-Square Distribution | 6 | 1998 | 179 |
Why?
| Bezoars | 1 | 1995 | 2 |
Why?
| New York | 2 | 2009 | 422 |
Why?
| Evaluation Studies as Topic | 3 | 1997 | 178 |
Why?
| Gastric Juice | 4 | 1992 | 8 |
Why?
| Mesenteric Arteries | 1 | 1995 | 18 |
Why?
| Bile | 2 | 1994 | 16 |
Why?
| Survival Analysis | 5 | 1993 | 205 |
Why?
| Combined Modality Therapy | 2 | 2002 | 219 |
Why?
| Heartburn | 6 | 1993 | 2 |
Why?
| Palliative Care | 3 | 1994 | 65 |
Why?
| Bile Ducts | 1 | 1994 | 9 |
Why?
| Tumor Cells, Cultured | 2 | 2007 | 233 |
Why?
| Reference Values | 5 | 1997 | 278 |
Why?
| Internship and Residency | 3 | 2001 | 175 |
Why?
| Gastritis | 3 | 1999 | 8 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2000 | 243 |
Why?
| Risk Factors | 6 | 2001 | 555 |
Why?
| Prognosis | 8 | 1994 | 388 |
Why?
| Helicobacter Infections | 3 | 1999 | 10 |
Why?
| Confidence Intervals | 3 | 1999 | 104 |
Why?
| Patient Satisfaction | 6 | 1995 | 120 |
Why?
| History, 21st Century | 2 | 2009 | 36 |
Why?
| Analysis of Variance | 5 | 1995 | 339 |
Why?
| Biopsy, Needle | 4 | 2001 | 94 |
Why?
| Cell Line | 2 | 2007 | 375 |
Why?
| Proctocolectomy, Restorative | 1 | 2001 | 10 |
Why?
| Sex Factors | 3 | 1999 | 284 |
Why?
| Diagnosis, Differential | 3 | 2000 | 402 |
Why?
| Esophagitis, Peptic | 5 | 1992 | 4 |
Why?
| Stents | 2 | 1994 | 55 |
Why?
| Cyclin-Dependent Kinase 6 | 1 | 2011 | 5 |
Why?
| Cyclin-Dependent Kinase 4 | 1 | 2011 | 9 |
Why?
| Spasm | 1 | 2011 | 9 |
Why?
| Gastroscopy | 4 | 1994 | 11 |
Why?
| Disease Progression | 5 | 1998 | 244 |
Why?
| Pancreatectomy | 1 | 1991 | 11 |
Why?
| Genes, erbB-2 | 1 | 2011 | 9 |
Why?
| Cell Differentiation | 2 | 2007 | 262 |
Why?
| SEER Program | 1 | 2010 | 22 |
Why?
| Receptor, erbB-2 | 1 | 2011 | 25 |
Why?
| Cell Line, Tumor | 2 | 2009 | 208 |
Why?
| Rectal Neoplasms | 1 | 2001 | 26 |
Why?
| Vascular Neoplasms | 1 | 2010 | 8 |
Why?
| Epithelium | 4 | 1999 | 101 |
Why?
| Chest Pain | 3 | 1993 | 12 |
Why?
| Supine Position | 2 | 1997 | 7 |
Why?
| Single-Blind Method | 3 | 2004 | 86 |
Why?
| Intestinal Secretions | 2 | 1995 | 2 |
Why?
| Ultrasonic Therapy | 2 | 1998 | 17 |
Why?
| World War II | 1 | 2009 | 2 |
Why?
| Databases, Factual | 1 | 2010 | 102 |
Why?
| Dipeptides | 1 | 2009 | 17 |
Why?
| Multivariate Analysis | 8 | 1999 | 225 |
Why?
| Registries | 1 | 2010 | 83 |
Why?
| Smoking | 2 | 1993 | 153 |
Why?
| England | 1 | 2009 | 20 |
Why?
| Case-Control Studies | 5 | 2000 | 283 |
Why?
| RNA-Binding Proteins | 1 | 2011 | 55 |
Why?
| Teaching | 1 | 2010 | 89 |
Why?
| Parathyroid Glands | 1 | 1999 | 10 |
Why?
| Embryonic Development | 1 | 2009 | 26 |
Why?
| Monitoring, Ambulatory | 8 | 1995 | 15 |
Why?
| Thyroidectomy | 1 | 1999 | 21 |
Why?
| Asthma | 2 | 2000 | 97 |
Why?
| Bilirubin | 6 | 1995 | 29 |
Why?
| Pressure | 7 | 1997 | 79 |
Why?
| Education, Medical, Graduate | 1 | 2010 | 70 |
Why?
| Referral and Consultation | 1 | 2010 | 134 |
Why?
| Bone Diseases, Metabolic | 1 | 2009 | 17 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 48 |
Why?
| Helicobacter pylori | 4 | 1999 | 10 |
Why?
| Keratins | 3 | 2002 | 27 |
Why?
| Quality of Life | 3 | 1998 | 188 |
Why?
| Task Performance and Analysis | 1 | 2008 | 25 |
Why?
| Posture | 2 | 1997 | 68 |
Why?
| Spinal Fractures | 1 | 2009 | 24 |
Why?
| Balloon Dilation | 2 | 2004 | 42 |
Why?
| Thyroid Neoplasms | 1 | 1999 | 43 |
Why?
| Intestinal Mucosa | 4 | 1997 | 56 |
Why?
| Histamine H2 Antagonists | 2 | 2000 | 7 |
Why?
| Carcinogens | 2 | 1998 | 40 |
Why?
| Hydrogen Sulfide | 1 | 1998 | 3 |
Why?
| Cell Culture Techniques | 1 | 2008 | 74 |
Why?
| Age Factors | 2 | 1999 | 480 |
Why?
| Feces | 1 | 1998 | 43 |
Why?
| Esophageal Stenosis | 3 | 1992 | 13 |
Why?
| Discriminant Analysis | 1 | 2007 | 21 |
Why?
| Principal Component Analysis | 1 | 2007 | 18 |
Why?
| DNA, Neoplasm | 3 | 2000 | 75 |
Why?
| Colitis, Ulcerative | 1 | 1998 | 21 |
Why?
| Immunohistochemistry | 6 | 2001 | 355 |
Why?
| Cross-Sectional Studies | 1 | 2010 | 253 |
Why?
| Ligands | 1 | 2008 | 116 |
Why?
| Bile Reflux | 1 | 2007 | 1 |
Why?
| Anastomosis, Roux-en-Y | 1 | 2007 | 9 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2003 | 94 |
Why?
| Ambulatory Surgical Procedures | 1 | 2006 | 12 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2005 | 176 |
Why?
| Treatment Failure | 1 | 2007 | 88 |
Why?
| Hoarseness | 1 | 2006 | 3 |
Why?
| Irritable Bowel Syndrome | 1 | 2006 | 2 |
Why?
| Antacids | 3 | 1992 | 7 |
Why?
| Transcriptional Activation | 1 | 2008 | 99 |
Why?
| Anorexia | 1 | 2006 | 3 |
Why?
| Conscious Sedation | 1 | 2006 | 26 |
Why?
| Stomach Diseases | 1 | 2006 | 7 |
Why?
| Video Recording | 2 | 2000 | 46 |
Why?
| Endosonography | 2 | 1999 | 10 |
Why?
| Abdominal Pain | 1 | 2006 | 15 |
Why?
| Intestinal Diseases | 1 | 2006 | 15 |
Why?
| Cough | 1 | 2006 | 20 |
Why?
| Forecasting | 2 | 1999 | 147 |
Why?
| Lung | 1 | 1993 | 232 |
Why?
| Angina Pectoris | 1 | 2006 | 31 |
Why?
| California | 4 | 1994 | 40 |
Why?
| Neoplasm Proteins | 2 | 2004 | 110 |
Why?
| Evoked Potentials | 1 | 2006 | 44 |
Why?
| Intermediate Filament Proteins | 2 | 2002 | 17 |
Why?
| Injections, Intralesional | 1 | 2005 | 15 |
Why?
| Feasibility Studies | 4 | 1993 | 144 |
Why?
| Weight Loss | 1 | 2006 | 51 |
Why?
| Polymerase Chain Reaction | 2 | 2004 | 279 |
Why?
| Digestive System Surgical Procedures | 2 | 2002 | 13 |
Why?
| Device Approval | 1 | 2005 | 7 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 71 |
Why?
| Phosphorylation | 1 | 2008 | 224 |
Why?
| Diagnostic Imaging | 1 | 2006 | 66 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 33 |
Why?
| Cystic Duct | 2 | 1994 | 2 |
Why?
| Surgical Staplers | 2 | 1995 | 2 |
Why?
| Ambulatory Care | 2 | 1993 | 106 |
Why?
| Cyclooxygenase 1 | 1 | 2004 | 41 |
Why?
| Nausea | 1 | 2006 | 34 |
Why?
| Surgical Wound Dehiscence | 1 | 2004 | 19 |
Why?
| Knowledge | 1 | 2004 | 10 |
Why?
| Swine | 5 | 1995 | 95 |
Why?
| Abdomen | 2 | 1999 | 51 |
Why?
| Outcome Assessment (Health Care) | 2 | 1995 | 163 |
Why?
| Anastomosis, Surgical | 3 | 1995 | 45 |
Why?
| Ischemia | 1 | 2004 | 65 |
Why?
| Biopolymers | 1 | 2003 | 12 |
Why?
| Reproducibility of Results | 4 | 1994 | 391 |
Why?
| Injections | 1 | 2003 | 53 |
Why?
| Membrane Proteins | 2 | 2004 | 233 |
Why?
| Fluoroscopy | 1 | 2003 | 27 |
Why?
| Zenker Diverticulum | 1 | 2002 | 3 |
Why?
| Laryngoscopes | 1 | 2002 | 7 |
Why?
| Vagus Nerve | 1 | 2002 | 25 |
Why?
| Mutagenesis | 1 | 2003 | 74 |
Why?
| Diverticulum, Esophageal | 1 | 2002 | 2 |
Why?
| Endothelial Growth Factors | 1 | 2003 | 47 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2003 | 49 |
Why?
| Pancreatitis | 2 | 1991 | 24 |
Why?
| Lymphokines | 1 | 2003 | 61 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 64 |
Why?
| Animals | 13 | 1995 | 1031 |
Why?
| Antibodies | 1 | 2002 | 159 |
Why?
| Ornithine Decarboxylase | 1 | 2001 | 9 |
Why?
| Gene Amplification | 2 | 2011 | 22 |
Why?
| Probability | 4 | 2001 | 190 |
Why?
| Abdominal Muscles | 1 | 2001 | 30 |
Why?
| Isoenzymes | 1 | 2004 | 144 |
Why?
| Receptors, Retinoic Acid | 1 | 2001 | 19 |
Why?
| Pain, Postoperative | 2 | 1995 | 42 |
Why?
| Cineradiography | 1 | 2000 | 6 |
Why?
| Carcinoma | 1 | 2002 | 109 |
Why?
| DNA Methylation | 1 | 2000 | 29 |
Why?
| CpG Islands | 1 | 2000 | 26 |
Why?
| Disease Models, Animal | 2 | 2000 | 349 |
Why?
| Educational Measurement | 1 | 2001 | 60 |
Why?
| Postoperative Care | 1 | 2001 | 84 |
Why?
| RNA | 2 | 2000 | 126 |
Why?
| Videotape Recording | 1 | 2000 | 45 |
Why?
| Antineoplastic Agents | 1 | 2006 | 190 |
Why?
| Gastric Fundus | 2 | 1994 | 4 |
Why?
| Telomerase | 1 | 2000 | 15 |
Why?
| Insufflation | 1 | 1999 | 2 |
Why?
| Genes, p53 | 1 | 2000 | 43 |
Why?
| Ascitic Fluid | 1 | 1999 | 20 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2000 | 121 |
Why?
| Body Temperature | 1 | 1999 | 44 |
Why?
| Up-Regulation | 1 | 2001 | 183 |
Why?
| Evidence-Based Medicine | 1 | 2001 | 125 |
Why?
| Pharyngeal Diseases | 1 | 1998 | 5 |
Why?
| Temperature | 1 | 1999 | 137 |
Why?
| Gastroplasty | 1 | 1998 | 3 |
Why?
| Jejunum | 1 | 1998 | 31 |
Why?
| Marketing of Health Services | 1 | 1998 | 13 |
Why?
| Brain | 1 | 2006 | 305 |
Why?
| Health Status Indicators | 1 | 1998 | 66 |
Why?
| Reconstructive Surgical Procedures | 1 | 1998 | 53 |
Why?
| Child | 6 | 1993 | 749 |
Why?
| Rats, Sprague-Dawley | 4 | 1996 | 257 |
Why?
| Hormones | 1 | 1996 | 36 |
Why?
| Vena Cava, Inferior | 1 | 1996 | 26 |
Why?
| Endoscopy, Gastrointestinal | 2 | 2003 | 17 |
Why?
| Carcinoembryonic Antigen | 1 | 1995 | 8 |
Why?
| Muscle Contraction | 1 | 1997 | 77 |
Why?
| Respiratory Tract Diseases | 1 | 1996 | 34 |
Why?
| Laparoscopes | 1 | 1995 | 3 |
Why?
| Stress, Physiological | 1 | 1996 | 76 |
Why?
| Hospital Charges | 1 | 1995 | 12 |
Why?
| Hepatic Duct, Common | 1 | 1994 | 3 |
Why?
| Hospitals, Urban | 1 | 1994 | 10 |
Why?
| Cytokines | 1 | 1999 | 207 |
Why?
| Cholestasis, Extrahepatic | 1 | 1994 | 7 |
Why?
| Intraoperative Period | 1 | 1994 | 43 |
Why?
| Appendectomy | 1 | 1995 | 13 |
Why?
| Heart | 1 | 1996 | 88 |
Why?
| Imino Acids | 1 | 1994 | 3 |
Why?
| Organotechnetium Compounds | 1 | 1994 | 6 |
Why?
| Intraoperative Complications | 2 | 1991 | 53 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1994 | 13 |
Why?
| Common Bile Duct | 1 | 1994 | 15 |
Why?
| Hospitals, Teaching | 1 | 1994 | 57 |
Why?
| Drainage | 1 | 1994 | 50 |
Why?
| Chronic Disease | 2 | 1991 | 267 |
Why?
| International Cooperation | 2 | 2003 | 42 |
Why?
| Maximal Midexpiratory Flow Rate | 1 | 1993 | 7 |
Why?
| Visual Perception | 1 | 1995 | 51 |
Why?
| Vital Capacity | 1 | 1993 | 25 |
Why?
| Spirometry | 1 | 1993 | 18 |
Why?
| Cholangiography | 1 | 1993 | 9 |
Why?
| Forced Expiratory Volume | 1 | 1993 | 29 |
Why?
| Mutation | 3 | 2000 | 340 |
Why?
| Safety | 1 | 1993 | 80 |
Why?
| Keratin-7 | 2 | 2002 | 5 |
Why?
| Keratin-20 | 2 | 2002 | 4 |
Why?
| Mass Screening | 1 | 1995 | 125 |
Why?
| Rats | 4 | 1996 | 530 |
Why?
| Postoperative Period | 2 | 2001 | 63 |
Why?
| DNA Copy Number Variations | 1 | 2011 | 5 |
Why?
| Rectum | 1 | 2001 | 29 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2011 | 21 |
Why?
| Acute Disease | 1 | 1993 | 271 |
Why?
| Common Bile Duct Neoplasms | 1 | 1991 | 4 |
Why?
| Gene Knockdown Techniques | 1 | 2011 | 26 |
Why?
| Duodenal Neoplasms | 1 | 1991 | 4 |
Why?
| Tissue Array Analysis | 1 | 2011 | 27 |
Why?
| Methods | 1 | 1991 | 133 |
Why?
| Intervention Studies | 1 | 2010 | 30 |
Why?
| Costs and Cost Analysis | 1 | 1991 | 71 |
Why?
| Pyridines | 1 | 2011 | 61 |
Why?
| Congresses as Topic | 1 | 2010 | 30 |
Why?
| Morbidity | 1 | 2010 | 62 |
Why?
| Piperazines | 1 | 2011 | 57 |
Why?
| Protein Kinase Inhibitors | 1 | 2011 | 59 |
Why?
| Problem-Based Learning | 1 | 2010 | 36 |
Why?
| Life Tables | 2 | 1994 | 33 |
Why?
| Laser Therapy | 1 | 1991 | 27 |
Why?
| Cell Transformation, Neoplastic | 2 | 2000 | 86 |
Why?
| In Situ Hybridization | 1 | 2011 | 135 |
Why?
| Pancreatic Neoplasms | 1 | 1991 | 46 |
Why?
| Mortality | 1 | 2010 | 50 |
Why?
| Questionnaires | 3 | 1996 | 360 |
Why?
| Academic Medical Centers | 1 | 2010 | 65 |
Why?
| Gastric Emptying | 2 | 1994 | 5 |
Why?
| Algorithms | 3 | 1993 | 226 |
Why?
| Phosphorus | 1 | 1999 | 29 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 135 |
Why?
| Transplantation, Autologous | 1 | 1999 | 78 |
Why?
| History, 19th Century | 1 | 2009 | 40 |
Why?
| Parathyroid Hormone | 1 | 1999 | 36 |
Why?
| Recurrence | 2 | 2000 | 261 |
Why?
| Quality of Health Care | 1 | 2010 | 85 |
Why?
| Vitamin D | 1 | 1999 | 41 |
Why?
| Chromatography, Gas | 1 | 1998 | 21 |
Why?
| Methane | 1 | 1998 | 6 |
Why?
| Sulfates | 1 | 1998 | 27 |
Why?
| Hydrogen | 1 | 1998 | 24 |
Why?
| Carbon Monoxide | 1 | 1998 | 24 |
Why?
| Sulfhydryl Compounds | 1 | 1998 | 42 |
Why?
| Bacteria | 1 | 1998 | 42 |
Why?
| Cell Proliferation | 1 | 2011 | 227 |
Why?
| Carcinogenicity Tests | 1 | 2007 | 5 |
Why?
| Data Interpretation, Statistical | 1 | 1998 | 109 |
Why?
| Cross-Over Studies | 1 | 2006 | 82 |
Why?
| RNA, Neoplasm | 1 | 2006 | 41 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2005 | 5 |
Why?
| Belgium | 1 | 2005 | 2 |
Why?
| Equipment Safety | 1 | 2005 | 25 |
Why?
| United States Food and Drug Administration | 1 | 2005 | 28 |
Why?
| Canada | 1 | 2005 | 60 |
Why?
| Hematoxylin | 1 | 2004 | 3 |
Why?
| Eosine Yellowish-(YS) | 1 | 2004 | 4 |
Why?
| Animals, Genetically Modified | 1 | 2005 | 29 |
Why?
| Lac Operon | 1 | 2005 | 38 |
Why?
| Proportional Hazards Models | 1 | 2006 | 123 |
Why?
| Catheterization | 1 | 2004 | 47 |
Why?
| Coloring Agents | 1 | 2004 | 42 |
Why?
| Neoplasm Metastasis | 1 | 2005 | 112 |
Why?
| Staining and Labeling | 1 | 2004 | 101 |
Why?
| Models, Animal | 1 | 2005 | 85 |
Why?
| Mice | 2 | 2005 | 623 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 80 |
Why?
| Immunoenzyme Techniques | 1 | 2004 | 125 |
Why?
| Goblet Cells | 1 | 2003 | 5 |
Why?
| Drug Implants | 1 | 2003 | 15 |
Why?
| Vascular Endothelial Growth Factors | 1 | 2003 | 39 |
Why?
| Pyloric Antrum | 1 | 2002 | 4 |
Why?
| Antigens, CD31 | 1 | 2003 | 17 |
Why?
| Inflammation | 1 | 2007 | 208 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 216 |
Why?
| Radiotherapy, Adjuvant | 1 | 2002 | 49 |
Why?
| Calcium | 1 | 1999 | 208 |
Why?
| Chemotherapy, Adjuvant | 1 | 2002 | 55 |
Why?
| Swine, Miniature | 1 | 2001 | 3 |
Why?
| Radiotherapy Dosage | 1 | 2002 | 55 |
Why?
| Illinois | 1 | 2001 | 9 |
Why?
| Regression Analysis | 1 | 2003 | 256 |
Why?
| Sex Distribution | 1 | 2002 | 101 |
Why?
| Mice, Inbred C57BL | 1 | 2007 | 318 |
Why?
| Age Distribution | 1 | 2002 | 127 |
Why?
| Disease-Free Survival | 1 | 2001 | 102 |
Why?
| Genes, APC | 1 | 2000 | 6 |
Why?
| Genes, p16 | 1 | 2000 | 10 |
Why?
| Estrogen Receptor alpha | 1 | 2000 | 20 |
Why?
| Psychometrics | 1 | 2001 | 97 |
Why?
| Cadherins | 1 | 2000 | 32 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 23 |
Why?
| Los Angeles | 1 | 1999 | 8 |
Why?
| Antibodies, Monoclonal | 1 | 2004 | 241 |
Why?
| Thorax | 1 | 1999 | 30 |
Why?
| Receptors, Estrogen | 1 | 2000 | 44 |
Why?
| Biology | 1 | 1999 | 5 |
Why?
| Incidence | 1 | 2002 | 336 |
Why?
| Diagnostic Errors | 1 | 1999 | 73 |
Why?
| Biomechanics | 1 | 1999 | 79 |
Why?
| Eating | 1 | 1998 | 37 |
Why?
| DNA Primers | 1 | 2000 | 208 |
Why?
| Remission Induction | 1 | 1998 | 64 |
Why?
| Mass Media | 1 | 1998 | 15 |
Why?
| Suction | 1 | 1997 | 13 |
Why?
| Body Mass Index | 1 | 1999 | 122 |
Why?
| Random Allocation | 1 | 1998 | 160 |
Why?
| Dilatation, Pathologic | 1 | 1997 | 15 |
Why?
| Papio | 1 | 1997 | 12 |
Why?
| Muscles | 1 | 1998 | 111 |
Why?
| Water | 1 | 1997 | 85 |
Why?
| Adrenocorticotropic Hormone | 1 | 1996 | 31 |
Why?
| Cells, Cultured | 1 | 2003 | 447 |
Why?
| Patient Education as Topic | 1 | 1998 | 128 |
Why?
| Carcinoma, Adenosquamous | 1 | 1995 | 3 |
Why?
| Hospitals, Public | 1 | 1995 | 6 |
Why?
| Operating Room Nursing | 1 | 1995 | 1 |
Why?
| Hydrocortisone | 1 | 1996 | 65 |
Why?
| Regional Blood Flow | 1 | 1996 | 105 |
Why?
| Aphasia | 1 | 1995 | 3 |
Why?
| Individuality | 1 | 1995 | 9 |
Why?
| Allied Health Personnel | 1 | 1995 | 16 |
Why?
| Homeostasis | 1 | 1996 | 99 |
Why?
| Hemodynamics | 1 | 1996 | 131 |
Why?
| DNA | 1 | 2000 | 262 |
Why?
| Gynecology | 1 | 1995 | 21 |
Why?
| Cholangitis | 1 | 1994 | 7 |
Why?
| Spectrophotometry | 1 | 1995 | 53 |
Why?
| Cholecystitis | 1 | 1994 | 11 |
Why?
| Hospital Costs | 1 | 1995 | 26 |
Why?
| Hospitals, University | 1 | 1995 | 59 |
Why?
| Blood Glucose | 1 | 1996 | 99 |
Why?
| DNA-Binding Proteins | 1 | 2000 | 204 |
Why?
| Syndrome | 1 | 1994 | 142 |
Why?
| Actuarial Analysis | 1 | 1993 | 21 |
Why?
| Pneumonia, Aspiration | 1 | 1993 | 9 |
Why?
| Professional Practice | 1 | 1993 | 42 |
Why?
| Biological Markers | 1 | 1995 | 262 |
Why?
| Infant | 1 | 1993 | 464 |
Why?
| Child, Preschool | 1 | 1993 | 554 |
Why?
|
|
Peters's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
